Emily J. Rowling

Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Dose escalation of tolinapant (ASTX660) in combination with standard radical chemoradiotherapy in cervical cancer : a study protocol for a phase 1b TiTE-CRM clinical trial (CRAIN) in UK secondary care centres.

Dose escalation of tolinapant (ASTX660) in combination with standard radical chemoradiotherapy in cervical cancer : a study protocol for a phase 1b TiTE-CRM clinical trial (CRAIN) in UK secondary care centres.

Journal: BMC cancer

Published: April 12, 2024

Cooperative behaviour and phenotype plasticity evolve during melanoma progression.

Cooperative behaviour and phenotype plasticity evolve during melanoma progression.

Journal: Pigment cell & melanoma research

Published: July 19, 2019

A PAX3/BRN2 rheostat controls the dynamics of BRAF mediated MITF regulation in MITFhigh /AXLlow melanoma.

A PAX3/BRN2 rheostat controls the dynamics of BRAF mediated MITF regulation in MITFhigh /AXLlow melanoma.

Journal: Pigment cell & melanoma research

Published: May 02, 2018

Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing.

Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing.

Journal: Oncogene

Published: September 27, 2017

Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure.

Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure.

Journal: EMBO molecular medicine

Published: June 14, 2017

An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition.

An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition.

Journal: The Journal of experimental medicine

Published: June 07, 2016

Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas.

Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas.

Journal: Oncotarget

Published: March 21, 2016

Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy.

Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy.

Journal: Cancer cell

Published: July 03, 2015

Detection of apoptosis by PET/CT with the diethyl ester of [¹⁸F]ML-10 and fluorescence imaging with a dansyl analogue.

Detection of apoptosis by PET/CT with the diethyl ester of [¹⁸F]ML-10 and fluorescence imaging with a dansyl analogue.

Journal: Bioorganic & medicinal chemistry

Published: August 23, 2013

GDC-0941 inhibits metastatic characteristics of thyroid carcinomas by targeting both the phosphoinositide-3 kinase (PI3K) and hypoxia-inducible factor-1α (HIF-1α) pathways.

GDC-0941 inhibits metastatic characteristics of thyroid carcinomas by targeting both the phosphoinositide-3 kinase (PI3K) and hypoxia-inducible factor-1α (HIF-1α) pathways.

Journal: The Journal of clinical endocrinology and metabolism

Published: October 14, 2011

Showing 1-10 of 10

Last Updated: 09/26/2026